Principal Scientist
CurrentExtensive experience in clinical pharmacology and clinical development of oncology drugs with the goal of obtaining drug approval. Contributed to the successful filing and approval from global health authorities on Genentech’s first small molecule, Erivedge. Provide essential clinical study design and data analysis in numerous clinical trials across multiple drug candidates in a variety of oncology indications. Over my tenure at Genentech, worked with increasing responsibilities from research associate to principal scientist.